DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAMRCSGP

Septal deviation and turbinate hypertrophy

Essential points for quick revision.

!
New obstruction after injury or surgery

A rapidly more blocked, painful or red nose after trauma or septal surgery may represent a septal haematoma or abscess rather than ordinary swelling.

Action: Arrange immediate ENT or emergency assessment and inspect the septum; a collection needs urgent specialist drainage and must not wait for a routine obstruction clinic.

Synopsis

Assess fixed and reversible causes of nasal obstruction, explain the limits of medical treatment, and select patients for a shared surgical decision.

  • A deviated septum is common and may be asymptomatic; an anatomical finding alone is not an indication for surgery.
  • Turbinate tissue changes in size with the nasal cycle and inflammation, so blockage can alternate or fluctuate.
  • Ask how obstruction affects sleep, exercise, work and daily comfort before discussing intervention.

Key red flags

Boggy septal swelling with increasing obstruction after trauma or surgery requires immediate assessment for a septal collection.

Investigation priorities

01
Clinical nasal assessmentFirst step

Relate reported obstruction to structural and mucosal findings.

Management branches

Low symptom burdenExplain the finding and observe

A septal deviation is present without important functional nasal obstruction.

  1. Explain that a bent septum can be left alone when its effect is acceptable to the patient.
  2. Offer advice about associated rhinitis or irritant exposure if these contribute to intermittent symptoms.

Key medicines

Mometasone furoate nasal spray for associated allergic mucosal swellingWith the 50-microgram Nasonex device, the usual adult rhinitis regimen is two sprays into each nostril once daily, or 200 micrograms daily. Review response and reduce to one spray per nostril daily when controlled; continue only while clinically needed.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom